About: Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. It is advancing a pipeline of medicines, including KP-104, a dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal nocturnal hemoglobinuria (PNH) and is under evaluation in other unmet need nephrology disorders; Briquilimab is an anti-KIT antibody, which has demonstrated clinical results as a conditioning agent for stem cell transplant and mast cell mediated diseases, such as chronic urticarias and allergic asthma; and KP-701, a novel, dual-acting anti-CD79BxCD32B monoclonal antibody (mAb) for autoantibody-mediated disorders. The company is based in Redwood City, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.52 (-5.44%)
JSPR NASDAQ Jasper Therapeutics Inc
Jasper Therapeutics Inc share price
JSPR price activity
Last Price
$0.560
Change (24hr)
-0.02 USD (-2.67%)
Volume
335.43K
Volume (4w avg)
-
Open
$0.57
Day Range
$0.56 - $0.57
Previous Close
$0.57
Last Trade
12 Oct, 8:00 pm GMT+0
Delayed
12 Oct, 8:00 pm GMT+0
JSPR price performance
Delayed
12 Oct, 8:00 pm GMT+0
JSPR Market Signals